CTRI/2023/03/050245已完成4 期
Prospective, Open label, observational, Multicenter study for evaluation of efficacy and safety of ACIDEEM Plus Tablet vs Pantoprazole 40mg for Reflux disease, regurgitation and heartburn, acidity in Indian adults for decreasing upper gastrointestinal symptoms.
Healing Hands & Herbs Pvt Ltd0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- 4 期
- 状态
- 已完成
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1.Patients aged 18 years of age.
- •2.Patient with diagnosis of uncomplicated symptomatic GERD.
- •3.Patient/Parent/legal guardian willing to give a written informed consent/parental consent/assent form.
- •4.Able to/Willing to strictly adhere to investigator’s prescription.
排除标准
- •1.Individuals were excluded if they had taken any medications which might interfere with the action of the study medications prior to the start of the study or during the study.
- •2.Patient having a clinical history or symptom profile suggestive of complicated GERD, other GI diseases (including Barrett’s oesophagus, acute peptic ulcer, or indication for Helicobacter pylori eradication therapy) or any severe diseases of other major body systems.
- •3.Patient having any existing conditions that might compromise their safety or participation in the study.
研究者
相似试验
已完成
4 期
A study to assess the safety and effectiveness of Indacaterol/ Mometasone DPI in asthma patients.CTRI/2023/05/052297Glenmark Pharmaceuticals Ltd174
已完成
不适用
Open label, prospective observational, multi-center trial in postmenopausal, hormone receptor positive breast cancer patients treated with eithertamoxifen or an aromatase inhibitor. Examination of the predictive value of biological markers AEBS/mEH, active tamoxifen metabolites and TGF beta system for response and non response of tamoxifen treatment.C50Malignant neoplasm of breastDRKS00000605Robert Bosch Gesellschaft für Medizinische Forschung mbH1,285
尚未招募
4 期
Assessing current practice pattern and best practice sharing of usage of Coseal(Surgical Sealant)CTRI/2012/10/003075Medanta The Medicity750
进行中（未招募）
1 期
Prospective, Open-label, Non-comparative, Multicenter Study for the Secondary Prophylaxis of Invasive Fungal Infections (IFI) with Voriconazole in Patients with Allogeneic Stem Cell TransplantsEUCTR2004-000365-35-ESPfizer S.A75
进行中（未招募）
1 期
Prospective, Open-label, Non-comparative, Multicenter Study for the Secondary Prophylaxis of Invasive Fungal Infections (IFI) with Voriconazole in Patients with Allogeneic Stem Cell TransplantsSecondary Prophylaxis of Invasive Fungal InfectionsMedDRA version: 7.0 Level: PT Classification code 10049085EUCTR2004-000365-35-GBPfizer Limited75